Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

NCT00322491 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Multiple Myeloma

Interventions

DRUG: G-CSF Plus Plerixafor

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]